SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-088054
Filing Date
2024-08-12
Accepted
2024-08-12 07:12:59
Documents
16
Period of Report
2024-08-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421372d1_8k.htm   iXBRL 8-K 26217
2 EXHIBIT 99.1 tm2421372d1_ex99-1.htm EX-99.1 16476
7 GRAPHIC tm2421372d1_ex99-1img001.jpg GRAPHIC 4959
  Complete submission text file 0001104659-24-088054.txt   272684

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20240812.xsd EX-101.SCH 3263
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrkr-20240812_def.xml EX-101.DEF 26192
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20240812_lab.xml EX-101.LAB 35952
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20240812_pre.xml EX-101.PRE 24850
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2421372d1_8k_htm.xml XML 5186
Mailing Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 241194723
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)